A 61-year-old man with Parkinson's disease.
Olanow
C W
CW
Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA.
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003863:Depression / Q000150:complications / Q000188:drug therapy; D015259:Dopamine Agents / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005194:Family Practice; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009462:Neurology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012642:Selegiline / Q000627:therapeutic use; D020280:Sertraline; D014810:Vitamin E / Q000627:therapeutic use
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D018696:Neuroprotective Agents; D014810:Vitamin E; D012642:Selegiline; D007980:Levodopa; D015057:1-Naphthylamine; D002230:Carbidopa; D020280:Sertraline